SCHEMBL8050802

SCHEMBL8050802

CCOC(=O)C1(C(N)=O)CC(OCc2ccccc2)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 2/20 0.43
EPHX2 P34913 1/20 0.41
TSHR P16473 2/20 0.40
ALDH1A1 P00352 3/20 0.39
CYP3A4 P08684 1/20 0.39
MAPK1 P28482 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
LMNA P02545 1/20 0.39
OPRM1 P35372 5/20 0.39
OPRL1 P41146 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
DPP4 P27487 1/20 0.39
NR1H4 Q96RI1 1/20 0.38
OPRD1 P41143 2/20 0.38
OPRK1 P41145 2/20 0.38
SLC22A1 O15245 1/20 0.38
SLC6A4 P31645 1/20 0.38
ADRA1A P35348 1/20 0.38
KCNH2 Q12809 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL871442 0.92 ADAM17 (0.46) ADAM17EPHX2TSHRALDH1A1CYP3A4
SCHEMBL8053435 0.90 ADAM17 (0.45) ADAM17EPHX2TSHRALDH1A1CYP3A4
Hydrochloric Acid SCHEMBL8049068 0.88 ADAM17 (0.44) ADAM17EPHX2TSHRALDH1A1CYP3A4
SCHEMBL8049066 0.87 EPHX2 (0.44) ADAM17EPHX2TSHRALDH1A1CYP3A4
SCHEMBL7936878 0.86 DPP4 (0.46) ADAM17EPHX2ALDH1A1OPRM1OPRL1
SCHEMBL8536152 0.85 OPRM1 (0.47) ADAM17EPHX2ALDH1A1LMNAOPRM1
SCHEMBL297404 0.84 ADAM17 (0.45) ADAM17EPHX2TSHRALDH1A1CYP3A4
SCHEMBL15306513 0.84 ADAM17 (0.45) ADAM17EPHX2TSHRALDH1A1CYP3A4
SCHEMBL15927866 0.83 ADAM17 (0.46) ADAM17EPHX2TSHRALDH1A1CYP3A4
SCHEMBL12277199 0.82 LMNA (0.46) ADAM17EPHX2TSHRALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6080750-A FOR PROPHYLAXIS AND TREATMENT OF DISEASES CAUSED BY INFECTION BY ROTAVIRUS NIPPON SHOJI KAISHA LTD. (JP) 2000-06-27 US disclosed
EP-0806418-A2 Novel pyrimidine compound and anti-rotavirus agent NIPPON SHOJI KAISHA, LIMITED (JP) 1997-11-12 EP disclosed